SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Immunotech Laboratories Announces Canadian Special Access Program Could Allow Legal Treatment of Company's Patented (IPF-ITV-1) AIDS-HIV Treatment